\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ abdominal\\ mass\ \(13\)\
\-\ normal\\ lab\\ exams\ \(0\)\
\-\ chemotherapy\ \(327\)\
\-\ ct\\ \ \(2714\)\
\-\ massive\\ retroperitoneal\\ and\\ mesenteric\\ lymphadenopathy\\.\ \(0\)\
\-\ sporadic\\ burkitt\\'s\\ lymphoma\\ \\(diffuse\\ small\\ noncleaved\\ cell\\ lymphoma\\)\ \(0\)\
\-\ nhl\\(3rd\\ most\\ common\\ malg\\.\\ childhood\\)\ \(0\)\
\-\ undifferentiated\\/small\\ noncleaved\\ nhl\\(burkitt\\)\ \(0\)\
\-\ hodgkin\\ lymphoma\ \(0\)\
\-\ acute\\ lymphocytic\\ leukemia\ \(5\)\
\-\ history\\ of\\ enlarging\\ abdomen\\ with\\ vague\\ consitutional\\ symptoms\\ for\\ several\\ months\\.\ \(0\)\
\-\ most\\ common\\ type\\ pediatric\\ non\\-hogkin\\ lymphoma\ \(0\)\
\-\ arise\\ from\\ undifferentiated\\ small\\ noncleaved\\ b\\-cell\\ lymphocytes\\.\\ histopathology\\ is\\ described\\ as\\ a\\ \\"starry\\-sky\\"\\ pattern\\.\\ it\\ is\\ the\\ fastest\\ growing\\ human\\ tumor\\ with\\ doubling\\ time\\ of\\ 24\\ hrs\\.\\ typically\\ no\\ peripheral\\ leukemia\\.\\ occurs\\ as\\ endemic\\ form\\ \\(seen\\ in\\ regions\\ w\\/\\ endemic\\ malaria\\)ex\\.\\ sub\\-saharan\\ africa\\ were\\ it\\ is\\ 80\\-90\\%\\ of\\ childhood\\ neoplasms\\.\\ presumed\\ exposure\\ to\\ plasmodium\\ falciparum\\ has\\ synergistic\\ effect\\ on\\ t\\-cell\\ surveillance\\.\\ associated\\ with\\ epstein\\-barr\\ virus\\ infection\\(95\\%\\)\\.\\ see\\ destructive\\ bone\\ lesions\\ in\\ the\\ face\\/jaw\\.\\ non\\-endemic\\ form\\ more\\ common\\ europe\\/north\\ america\\ were\\ it\\ is\\ 35\\-45\\%ped\\ nhl\\;3\\%\\ childhood\\ neoplasm\\.\\ epstein\\-barr\\ isolated\\ in\\ minority\\ of\\ cases\\.\\ see\\ involvement\\ abdomen\\ w\\/\\ small\\ bowel\\ and\\ mesentery\\(ususally\\ intraabdominal\\ extranodal\\)with\\ well\\ defined\\ homogenous\\ tumor\\.\\ can\\ infiltrate\\ organs\\(kidneys\\,ovary\\,retroperitoneum\\)\\.\\ pleual\\ effusion\\/ascited\\ common\\.\\ demonstrate\\ dramatic\\ response\\ to\\ chemotherapy\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ noncleaved\\:\\ 0\\.30672722686649473\ \(0\)\
\-\ nhl\\:\\ 0\\.2646054747380593\ \(0\)\
\-\ endemic\\:\\ 0\\.25261296381873094\ \(0\)\
\-\ childhood\\:\\ 0\\.19409312674802884\ \(0\)\
\-\ burkitt\\:\\ 0\\.16627222787946855\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.1625276457447886\ \(0\)\
\-\ lymphoma\\:\\ 0\\.15230368039610445\ \(0\)\
\-\ common\\:\\ 0\\.14502880200549037\ \(0\)\
\-\ small\\:\\ 0\\.13191469280814533\ \(0\)\
\-\ leukemia\\:\\ 0\\.11679530414591859\ \(0\)\
\-\ form\\:\\ 0\\.11179345485019487\ \(0\)\
\-\ cell\\:\\ 0\\.10971746084056654\ \(0\)\
\-\ malg\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ consitutional\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ fastest\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ doubling\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ plasmodium\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ ususally\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ pleual\\:\\ 0\\.10224240895549826\ \(0\)\
\-\ it\\:\\ 0\\.09817886600889715\ \(0\)\
\-\ falciparum\\:\\ 0\\.09769808008404542\ \(0\)\
\-\ synergistic\\:\\ 0\\.0944738274381352\ \(0\)\
\-\ extranodal\\:\\ 0\\.0944738274381352\ \(0\)\
\-\ africa\\:\\ 0\\.09197290279027336\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.09079298513857054\ \(0\)\
\-\ minority\\:\\ 0\\.08992949856668236\ \(0\)\
\-\ ped\\:\\ 0\\.08820182491268642\ \(0\)\
\-\ malaria\\:\\ 0\\.08670524592077217\ \(0\)\
\-\ intraabdominal\\:\\ 0\\.08043324339532337\ \(0\)\
\-\ retroperitoneum\\:\\ 0\\.07965999240145746\ \(0\)\
\-\ see\\:\\ 0\\.07954024860231196\ \(0\)\
\-\ human\\:\\ 0\\.07825720219141567\ \(0\)\
\-\ ex\\:\\ 0\\.07825720219141567\ \(0\)\
\-\ abdomen\\:\\ 0\\.07801928151925118\ \(0\)\
\-\ hrs\\:\\ 0\\.0770106193048255\ \(0\)\
\-\ america\\:\\ 0\\.07536753242237122\ \(0\)\
\-\ virus\\:\\ 0\\.07349524135503124\ \(0\)\
\-\ sporadic\\:\\ 0\\.07266466187796032\ \(0\)\
\-\ dramatic\\:\\ 0\\.07266466187796032\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.07189141088409441\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.07189141088409441\ \(0\)\
\-\ is\\:\\ 0\\.07003368788880812\ \(0\)\
\-\ surveillance\\:\\ 0\\.06984800666050343\ \(0\)\
\-\ mesentery\\:\\ 0\\.06954092734107152\ \(0\)\
\-\ destructive\\:\\ 0\\.06812033300650748\ \(0\)\
\-\ homogenous\\:\\ 0\\.06785661039116406\ \(0\)\
\-\ infiltrate\\:\\ 0\\.06785661039116406\ \(0\)\
\-\ tumor\\:\\ 0\\.0668810905678314\ \(0\)\
\-\ most\\:\\ 0\\.0665450934493344\ \(0\)\
\-\ organs\\:\\ 0\\.06594429180259978\ \(0\)\
\-\ were\\:\\ 0\\.06591098570903615\ \(0\)\
\-\ massive\\:\\ 0\\.06572665983766819\ \(0\)\
\-\ presumed\\:\\ 0\\.0653036777890506\ \(0\)\
\-\ exams\\:\\ 0\\.06489608036059728\ \(0\)\
\-\ histopathology\\:\\ 0\\.06450278758504925\ \(0\)\
\-\ growing\\:\\ 0\\.06272003915668957\ \(0\)\
\-\ vague\\:\\ 0\\.06255642027957427\ \(0\)\
\-\ ovary\\:\\ 0\\.06255642027957427\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.0616219047188695\ \(0\)\
\-\ exposure\\:\\ 0\\.060759348917597746\ \(0\)\
\-\ isolated\\:\\ 0\\.060759348917597746\ \(0\)\
\-\ 95\\:\\ 0\\.060621829474110864\ \(0\)\
\-\ enlarging\\:\\ 0\\.05970372742968574\ \(0\)\
\-\ neoplasms\\:\\ 0\\.059578500495278526\ \(0\)\
\-\ response\\:\\ 0\\.058972531622237534\ \(0\)\
\-\ arise\\:\\ 0\\.05851029316210248\ \(0\)\
\-\ 3rd\\:\\ 0\\.05839765207295929\ \(0\)\
\-\ lab\\:\\ 0\\.057744591979252836\ \(0\)\
\-\ pediatric\\:\\ 0\\.05722801695225563\ \(0\)\
\-\ mesenteric\\:\\ 0\\.05520145374465061\ \(0\)\
\-\ kidneys\\:\\ 0\\.05503417162382568\ \(0\)\
\-\ regions\\:\\ 0\\.05486934962352422\ \(0\)\
\-\ described\\:\\ 0\\.05187235754625622\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.05168607579485635\ \(0\)\
\-\ as\\:\\ 0\\.05136812115451464\ \(0\)\
\-\ occurs\\:\\ 0\\.05040712876787368\ \(0\)\
\-\ with\\:\\ 0\\.0500753384223119\ \(0\)\
\-\ of\\:\\ 0\\.05004543628605614\ \(0\)\
\-\ pattern\\:\\ 0\\.04773176178089664\ \(0\)\
\-\ in\\:\\ 0\\.04771319092677048\ \(0\)\
\-\ involvement\\:\\ 0\\.04627311072375675\ \(0\)\
\-\ peripheral\\:\\ 0\\.04571724338265062\ \(0\)\
\-\ defined\\:\\ 0\\.04560930327998924\ \(0\)\
\-\ 24\\:\\ 0\\.04532644425357629\ \(0\)\
\-\ palpable\\:\\ 0\\.04491510656343974\ \(0\)\
\-\ typically\\:\\ 0\\.044881500259310134\ \(0\)\
\-\ effect\\:\\ 0\\.04484799442260732\ \(0\)\
\-\ neoplasm\\:\\ 0\\.043643751371782065\ \(0\)\
\-\ cases\\:\\ 0\\.0430014681804757\ \(0\)\
\-\ type\\:\\ 0\\.042888543355834724\ \(0\)\
\-\ several\\:\\ 0\\.041946165505063686\ \(0\)\
\-\ bowel\\:\\ 0\\.04102922415803292\ \(0\)\
\-\ diffuse\\:\\ 0\\.04009375681659387\ \(0\)\
\-\ infection\\:\\ 0\\.03861908925693698\ \(0\)\
\-\ time\\:\\ 0\\.037894561869510866\ \(0\)\
\-\ months\\:\\ 0\\.03721404147935208\ \(0\)\
\-\ lesions\\:\\ 0\\.036717312000450954\ \(0\)\
\-\ more\\:\\ 0\\.035105925901721936\ \(0\)\
\-\ symptoms\\:\\ 0\\.03498038725717215\ \(0\)\
\-\ abdominal\\:\\ 0\\.034966524925126814\ \(0\)\
\-\ bone\\:\\ 0\\.034883709075188334\ \(0\)\
\-\ associated\\:\\ 0\\.03369736129356846\ \(0\)\
\-\ can\\:\\ 0\\.03354988950760495\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03323687233689251\ \(0\)\
\-\ to\\:\\ 0\\.03196613118265723\ \(0\)\
\-\ well\\:\\ 0\\.030956559829218733\ \(0\)\
\-\ seen\\:\\ 0\\.03009902796874632\ \(0\)\
\-\ has\\:\\ 0\\.029202624069530978\ \(0\)\
\-\ and\\:\\ 0\\.02642184619774569\ \(0\)\
\-\ normal\\:\\ 0\\.026103319139452026\ \(0\)\
\-\ the\\:\\ 0\\.025513806279673163\ \(0\)\
\-\ from\\:\\ 0\\.025391383670359723\ \(0\)\
\-\ history\\:\\ 0\\.02442601722880749\ \(0\)\
\-\ mass\\:\\ 0\\.02442060941493666\ \(0\)\
\-\ ct\\:\\ 0\\.02433980377269137\ \(0\)\
\-\ no\\:\\ 0\\.02079020760630841\ \(0\)\
\-\ for\\:\\ 0\\.01937753031646034\ \(0\)\
\-\ on\\:\\ 0\\.0193087923271241\ \(0\)\
